Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114693) titled 'Clinical Efficacy and Immunoregulatory Mechanisms of Minimally Invasive Corneal Neurotization (MICN) for Neurotrophic Keratopathy (NK): A Disease-Specific Cohort Study' on Dec. 16, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Condition:
Neurotrophic keratopathy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sample Size: Observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3002...